As a Biopharmaceutical company listed on the ASX (ASX:CXS) ChemGenex Pharmaceuticals is a leader in the Australian Biotech sector. Oncology is the primary focus with a developing late stage product pipeline.

Download our latest Annual Report

Download our latest Corporate Presentation

Download a Corporate Factsheet

Download Share Registry details

Latest News

February 9th, 2010

Extreme Weather in Washington D.C. has Postponed the FDA’s Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010

December 17th, 2009

ChemGenex Pharmaceuticals Announces Omapro™ to be Reviewed by the FDA’s Oncologic Drugs Advisory Committee

December 14th, 2009

ChemGenex, Hospira, Announce Agreement to License, Develop and Commercialize Leukemia Drug in Europe